Characterization and radiosensitivity of HPV-related oropharyngeal squamous cell carcinoma patient-derived xenografts

Distinguishing recurrence and new primary tumor as well as the origin of neck metastases in head and neck cancer clinical trials by targeted DNA sequencing

(2019) Jacob Kinggaard Lilja-Fischer et al.   ACTA ONCOLOGICA

Prognostic impact of HPV-associated p16-expression and smoking status on outcomes following radiotherapy for oropharyngeal cancer: The MARCH-HPV project

(2018) Pernille Lassen et al.   RADIOTHERAPY AND ONCOLOGY

Dual use of hematopoietic and mesenchymal stem cells enhances engraftment and immune cell trafficking in an allogeneic humanized mouse model of head and neck cancer

(2018) John J. Morton et al.   MOLECULAR CARCINOGENESIS

Human papillomavirus and the landscape of secondary genetic alterations in oral cancers

(2018) Maura L. Gillison et al.   GENOME RESEARCH

A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study

(2017) Jacob G Scott et al.   LANCET ONCOLOGY

Barriers to generating PDX models of HPV-related head and neck cancer

(2017) Nicole D. Facompre et al.   LARYNGOSCOPE

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution

(2017) Christopher Abbosh et al.   NATURE

Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials

(2016) Kasper Toustrup et al.   ACTA ONCOLOGICA

Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study

(2015) Jens Bentzen et al.   ACTA ONCOLOGICA

Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma

(2015) Maura L. Gillison et al.   JOURNAL OF CLINICAL ONCOLOGY

Comprehensive genomic characterization of head and neck squamous cell carcinomas

(2015)   NATURE

Patient-Derived Xenografts as a Model System for Radiation Research

(2015) Christopher D. Willey et al.   SEMINARS IN RADIATION ONCOLOGY

Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes

(2014) M. K. Keck et al.   CLINICAL CANCER RESEARCH

Patient-Derived Tumor Xenografts: Transforming Clinical Samples into Mouse Models

(2013) D. Siolas et al.   CANCER RESEARCH

A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins

(2013) Stephen B. Keysar et al.   Molecular Oncology

Development and Characterization of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Tumorgrafts

(2012) R. J. Kimple et al.   CLINICAL CANCER RESEARCH

Patient-derived tumour xenografts as models for oncology drug development

(2012) John J. Tentler et al.   Nature Reviews Clinical Oncology

Development of a Hypoxia Gene Expression Classifier with Predictive Impact for Hypoxic Modification of Radiotherapy in Head and Neck Cancer

(2011) K. Toustrup et al.   CANCER RESEARCH

Frequency of cells expressing CD44, a Head and Neck cancer stem cell marker: Correlation with tumor aggressiveness

(2011) Benzion Joshua et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Identifying pH independent hypoxia induced genes in human squamous cell carcinomasin vitro

(2010) Brita Singers Sørensen et al.   ACTA ONCOLOGICA

Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer

(2010) K. Kian Ang et al.   NEW ENGLAND JOURNAL OF MEDICINE

The role of Human papillomavirus in head and neck cancer and the impact on radiotherapy outcome

(2010) Pernille Lassen   RADIOTHERAPY AND ONCOLOGY

A Gene Expression Model of Intrinsic Tumor Radiosensitivity: Prediction of Response and Prognosis After Chemoradiation

(2009) Steven A. Eschrich et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Effect of HPV-Associated p16INK4A Expression on Response to Radiotherapy and Survival in Squamous Cell Carcinoma of the Head and Neck

(2009) Pernille Lassen et al.   JOURNAL OF CLINICAL ONCOLOGY